We are a biopharma company that partners with top-tier researchers to accelerate new discoveries in the world of medicine, one powerful idea at a time!

Joined January 2020
60 Photos and videos
It looks like Ocean Biomedical was the best performing stock on the #Russell2000 in '24 Q1! investorsobserver.com/news/q… #biopharma #innovation #research #globalhealth $ocea

7
1
5
1,645
It’s always nice to be mentioned with $NVDA… “This treatment is particularly special, as according to the firm, it is the first human data from a genetically modified #T-Cell vaccine.’ #biopharma #discovery $ocea finance.yahoo.com/news/13-ho…

2
2
1,151
Congratulations to our partners at Virion for solid Phase 1 study data, the first ever for a checkpoint modifier containing T cell vaccine of any kind. We are proud of this groundbreaking work towards creating a functional cure for #HBV! $ocea bit.ly/3vliYdn

2
896
CEO Elizabeth Ng is featured on the front page of the MIT Alumni News website today: alum.mit.edu/slice/helping-m… #cancer #biopharma $ocea
1
1
4
824
Ocean Biomedical retweeted
Today, @WHO published the World Malaria Report 📑 which explores the impacts of climate change on #malaria transmission. Robust surveillance 📈 is critical in ensuring malaria programmes can respond to the impact of changing weather. Read more 📰#COP28 brnw.ch/21wETZV
2
37
61
5,311
Ocean Biomedical CEO, Elizabeth Ng, CFO Gurinder Kalra, and Executive Chairman, Chirinjeev Kathuria will be presenting today at 12:35pm... Presenting on the Emerging Growth Conference 64 Day 1 on November 1 globenewswire.com/news-relea… $ocea
1
369
Ocean Biomedical retweeted
While we’ve been giving tips throughout the month, today is officially Lung Health Day! #curehps
1
2
284
We're in! 🍾 First patients dosed in Hong Kong today in a groundbreaking, international HBV study with our partner Virion Therapeutics, evaluating a new "functional cure" for chronic Hep B infection. #FPI #HBV #biopharma $OCEA bit.ly/3s5WmvI
2
1
1,059
Ocean Biomedical retweeted
26 Oct 2023
EXCLISIVE: .@OceanBiomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B benzinga.com/news/23/10/3543… $OCEA $QQQ
1
1
4,046